Mark Owen
Hematology & Oncology · Cleveland, TNNPI 1811761588
Payments from drug & device makers
Across 104 payments — averaging $23.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$330
- Daiichi Sankyo Inc.$290
- Incyte Corporation$204
- AstraZeneca$148
- Bristol Myers Squibb$123
- GSK$108
- plus $1K from 29 others
What the payments were for
- Food & beverage$2,35296%
- Education$884%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 20 | $330 |
| Daiichi Sankyo Inc. | 11 | $290 |
| Incyte Corporation | 6 | $204 |
| AstraZeneca(2 entities) | 6 | $148 |
| Bristol Myers Squibb | 5 | $123 |
| GSK | 5 | $108 |
| Pfizer | 5 | $105 |
| Bayer | 3 | $104 |
| Regeneron Healthcare Solutions, Inc. | 3 | $92 |
| Exelixis Inc. | 2 | $76 |
| Tersera Therapeutics LLC | 3 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $70 |
| Johnson & Johnson | 3 | $55 |
| Sanofi | 2 | $53 |
| Astellas Pharma US Inc | 2 | $52 |
| Sun Pharmaceutical Industries Inc. | 2 | $47 |
| Merck | 2 | $43 |
| Gilead | 2 | $43 |
| Lilly USA, LLC | 2 | $39 |
| Dendreon Pharmaceuticals LLC | 1 | $35 |
| Pharmacosmos Therapeutics Inc. | 2 | $35 |
| E.r. Squibb & Sons, L.L.C. | 1 | $34 |
| Ipsen Biopharmaceuticals, Inc | 1 | $33 |
| Eisai Inc. | 1 | $30 |
| Medline Industries LP | 1 | $28 |
| Deciphera Pharmaceuticals Inc. | 1 | $27 |
| Geron Corporation | 1 | $22 |
| EMD Serono, Inc. | 1 | $21 |
| Genmab U.S., Inc. | 1 | $20 |
| Sobi, Inc | 1 | $19 |
| Boehringer Ingelheim | 1 | $19 |
| AbbVie | 1 | $18 |
| Taiho Oncology, Inc. | 1 | $18 |
| Genentech USA, Inc. | 1 | $15 |
| Puma Biotechnology, Inc. | 1 | $15 |
How this compares
$2,440 in reported general payments places this provider in the 20th percentile of 251 hematology & oncology providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 48 | $1,075 |
| Prochlorperazine Maleate | 13 | $296 |
| Ondansetron OdtOndansetron | 16 | $197 |
| Duloxetine Hcl | 12 | $168 |
| Gabapentin | 11 | $57 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Cleveland
- Erika HamiltonNashville$45.4M
- Ian FlinnNashville$41.2M
- Johanna BendellNashville$28.5M
- Jesus BerdejaNashville$22.2M
- Meredith McKeanNashville$16M
- Krish PatelNashville$14.2M
- Kathryn BeckermannFranklin$13.6M
- Denise YardleyNashville$13.2M
- Todd BauerNashville$10.9M
- Bertrand AnzChattanooga$9.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.